Provided by Tiger Fintech (Singapore) Pte. Ltd.

Moderna, Inc.

25.85
-1.2718-4.69%
Volume:4.97M
Turnover:129.97M
Market Cap:10.06B
PE:-3.43
High:27.22
Open:27.12
Low:25.82
Close:27.12
52wk High:84.28
52wk Low:23.15
Shares:389.08M
Float Shares:363.29M
Volume Ratio:2.24
T/O Rate:1.37%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.5273
EPS(LYR):-9.2734
ROE:-27.50%
ROA:-14.78%
PB:1.07
PE(LYR):-2.79

Loading ...

Mixed options sentiment in Moderna with shares down 0.33%

TIPRANKS
·
Aug 15

Biogen, Moderna, Align Technology, QuidelOrtho, and Masimo Shares Skyrocket, What You Need To Know

stock_story_highlight
·
Aug 14

Moderna Stock Jumps as NIH Chief Tempers Administration's Attack on mRNA -- Barrons.com

Dow Jones
·
Aug 14

Moderna Inc. Stock Sheds 2.5%, Underperforms Competitors

Dow Jones
·
Aug 12

Moderna (MRNA) Gets a Hold from Bernstein

TIPRANKS
·
Aug 07

Analysts Are Neutral on These Healthcare Stocks: Moderna (MRNA), Twist Bioscience (TWST)

TIPRANKS
·
Aug 07

Moderna's stock takes a hit as RFK Jr. backs out of some mRNA vaccine deals

Dow Jones
·
Aug 07

US Health Department Ending Federal mRNA Vaccine Development

MT Newswires Live
·
Aug 06

Moderna Reports Q2 2025 Results: Revenue Drops to $0.1 Billion, Posts Net Loss of $(0.8) Billion, EPS at $(2.13); Lowers 2025 Revenue Forecast by $300 Million

Reuters
·
Aug 05

Moderna (MRNA) Gets a Hold from Evercore ISI

TIPRANKS
·
Aug 05

Berenberg Bank Sticks to Their Hold Rating for Moderna (MRNA)

TIPRANKS
·
Aug 05

20 Stocks Of S&P 500 Companies Showing The Fastest Sales Growth

Dow Jones
·
Aug 05

Moderna Is Maintained at Equal-Weight by Barclays

Dow Jones
·
Aug 05

UBS Remains a Buy on Moderna (MRNA)

TIPRANKS
·
Aug 05

Moderna Beat COVID Vaccine Revenue Estimates But Still Lowered 2025 Outlook, RBC Says

MT Newswires Live
·
Aug 04

Moderna (MRNA) Receives a Sell from Leerink Partners

TIPRANKS
·
Aug 04

Oppenheimer Remains a Hold on Moderna (MRNA)

TIPRANKS
·
Aug 04

Leerink Partners Adjusts Moderna Price Target to $18 From $20, Maintains Underperform Rating

MT Newswires Live
·
Aug 04

Moderna price target lowered to $24 from $25 at BofA

TIPRANKS
·
Aug 04

BUZZ-Street View: Brokerages bet on Moderna's cancer vaccine pipeline

Reuters
·
Aug 04